Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma

Br J Dermatol. 2011 Mar;164(3):665-7. doi: 10.1111/j.1365-2133.2010.10108.x. Epub 2011 Jan 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Antipruritics / administration & dosage*
  • Aprepitant
  • Female
  • Humans
  • Lymphoma, T-Cell, Cutaneous / complications*
  • Male
  • Middle Aged
  • Morpholines / administration & dosage*
  • Neurokinin-1 Receptor Antagonists*
  • Prospective Studies
  • Pruritus / drug therapy*
  • Pruritus / etiology
  • Quality of Life
  • Surveys and Questionnaires

Substances

  • Antipruritics
  • Morpholines
  • Neurokinin-1 Receptor Antagonists
  • Aprepitant